262 results
Page 2 of 14
8-K
EX-99.1
ul9fwkq 08djamgoxez
13 Sep 22
Alnylam Announces Proposed Offering of $900 Million Convertible Senior Notes
4:05pm
8-K
EX-99.1
q59ynf9 ox6gaw1uz0
28 Jul 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
ooya7bud0 dy29jtp
14 Jun 22
Other Events
7:30am
8-K
EX-99.1
ogoszy6ahvg5fxagip
28 Apr 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
juf33izytwaeblbs5we
5 Apr 22
Alnylam Announces Retirement of Steven Paul, M.D. from Board of Directors
4:16pm
8-K
EX-99.1
gzcppry jizzoasimr
4 Apr 22
Alnylam Announces 3-Month Extension of Review Period for New Drug Application for Vutrisiran
7:35am
8-K
EX-99.1
w78g8q4494 6xp
10 Feb 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
zowol8sur51v6l2u2iw
10 Jan 22
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2021 Global Net Product Revenues and Provides Additional Updates
7:01am
8-K
EX-99.1
2kvbwxcl8z4 y4csb
4 Jan 22
Alnylam Announces Promotion of Dr. Akshay Vaishnaw to President
4:16pm
8-K
yk50v is67i7ix5
28 Oct 21
Alnylam Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Period Activity
8:11am
8-K
EX-99.2
xm83h
28 Oct 21
Alnylam Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Period Activity
8:11am
8-K
EX-99.1
pfzeafw4h2 zsx47s
28 Oct 21
Alnylam Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Period Activity
8:11am
8-K
EX-99.1
d52c6r msy
3 Aug 21
Alnylam Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights
8:10am
8-K
628vdzl
3 Aug 21
Alnylam Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights
8:10am